Australia - English - Department of Health (Therapeutic Goods Administration)

pfizer australia pty ltd - bupivacaine hydrochloride monohydrate, quantity: 105.4 mg - injection, solution - excipient ingredients: sodium chloride; water for injections; sodium hydroxide; hydrochloric acid - bupivacaine injection is indicated for the production of local or regional anaesthesia and analgesia in individuals as follows: surgical anaesthesia - epidural block for surgery - field block (minor and major nerve blocks and infiltration). analgesia - continuous epidural infusion or intermittent bolus epidural administration for analgesia in post operative pain or labour pain. - field block (minor nerve block amd infiltration). the choice of 2 strengths, 0.25% and 0.5%, makes it possible to vary the degree of motor blockade.

Australia - English - Department of Health (Therapeutic Goods Administration)

brady australia pty ltd - 44039 - first aid kit, medicated - a procedure pack for the workplace, home, office, travel or sporting. a collection of materials and medicines for rapid, initial treatment of minor to moderate injuries. this procedure pack contains combinations of: saline, bandages, dressings, sheets, adhesive tapes, wipes, instruments and therapeutic relief product. the items included in each procedure pack are mutually compatible for use as a procedure pack. the procedure pack is supplied non-sterile but may contain sterile, single use and/or reusable components.

Australia - English - Department of Health (Therapeutic Goods Administration)

brady australia pty ltd - 44039 - first aid kit, medicated - procedure pack for the workplace, home, office, travel or sporting. a collection of materials and medicines used for rapid, initial treatment of minor to moderate injuries. the procedure pack contains combinations of: saline, bandages, dressings, sheets, adhesive tapes, wipes, instruments and therapeutic relief products. the items included in each procedure pack are mutually compatible for use as a procedure pack. the procedure pack is supplied non-sterile but may contain sterile, single use and or/reusable components.

Australia - English - Department of Health (Therapeutic Goods Administration)

brady australia pty ltd - 44039 - first aid kit, medicated - procedure pack for the workplace, home, office, travel or sporting. a collection of materials and medicines used for rapid, initial treatment of minor to moderate injuries. these procedure packs contain combinations of bandages, dressings, sheets, adhesive tapes, wipes, instruments and therapeutic relief products. the items included in each procedure pack are mutually compatible for use as a procedure pack. the procedure pack is supplied non-sterile but may contain sterile, single use and/or reusable components.

Australia - English - Department of Health (Therapeutic Goods Administration)

brady australia pty ltd - 44039 - first aid kit, medicated - procedure pack for the workplace, home, office, travel or sporting. a collection of equipment for the initial treatment of minor injuries. the kits contain combinations of: bandages, dressings, adhesive tapes, wipes, instruments and therapeutic relief products. the items included in each kit are mutually compatible for use as a procedure pack.

Australia - English - Department of Health (Therapeutic Goods Administration)

fair-med healthcare australia pty ltd - bisoprolol fumarate -

Australia - English - Department of Health (Therapeutic Goods Administration)

fair-med healthcare australia pty ltd - bisoprolol fumarate -

Australia - English - Department of Health (Therapeutic Goods Administration)

fair-med healthcare australia pty ltd - bisoprolol fumarate -

Australia - English - Department of Health (Therapeutic Goods Administration)

amdipharm mercury australia pty ltd - lanreotide acetate, quantity: 66.67 mg (equivalent: lanreotide, qty 60 mg) - injection, solution - excipient ingredients: glacial acetic acid; water for injections - mytolac is indicated for:,- the treatment of acromegaly when the circulating levels of growth hormone and igf-1 remain abnormal after surgery and/or radiotherapy or in patients who are dopamine agonist treatment refractory,- the treatment of symptoms of carcinoid syndrome associated with carcinoid tumours,- the treatment of gastroenteropancreatic neuroendocrine tumours (gep-nets) in adult patients with unresectable locally advanced or metastatic disease.

Australia - English - Department of Health (Therapeutic Goods Administration)

amdipharm mercury australia pty ltd - lanreotide acetate, quantity: 133.33 mg (equivalent: lanreotide, qty 120 mg) - injection, solution - excipient ingredients: water for injections; glacial acetic acid - mytolac is indicated for:,- the treatment of acromegaly when the circulating levels of growth hormone and igf-1 remain abnormal after surgery and/or radiotherapy or in patients who are dopamine agonist treatment refractory,- the treatment of symptoms of carcinoid syndrome associated with carcinoid tumours,- the treatment of gastroenteropancreatic neuroendocrine tumours (gep-nets) in adult patients with unresectable locally advanced or metastatic disease.